GIM
AGN

Groesbeck Investment Management’s Allergan plc AGN Stock Holding History

Groesbeck Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,175
Closed -$241K – 98
2017
Q3 		$241K Hold
1,175
– – 0.17% 85
2017
Q2 		$286K Hold
1,175
– – 0.21% 79
2017
Q1 		$281K Sell
1,175
-100
-8% -$23.3K 0.21% 77
2016
Q4 		$268K Sell
1,275
-2,276
-64% -$471K 0.21% 79
2016
Q3 		$818K Sell
3,551
-5,379
-60% -$1.31M 0.61% 39
2016
Q2 		$2.06M Sell
8,930
-16,045
-64% -$3.7M 1.51% 25
2016
Q1 		$6.69M Sell
24,975
-151
-0.6% -$43.2K 4.79% 2
2015
Q4 		$7.85M Sell
25,126
-31
-0.1% -$9.23K 5% 1
2015
Q3 		$6.84M Buy
25,157
+90
+0.4% +$27.6K 4.31% 2
2015
Q2 		$7.61M Buy
25,067
+310
+1% +$92.5K 3.65% 2
2015
Q1 		$7.37M Buy
24,757
+4,452
+22% +$1.27M 3.57% 2
2014
Q4 		$5.23M Buy
20,305
+4,630
+30% +$1.16M 2.57% 12
2014
Q3 		$3.78M Buy
15,675
+200
+1% +$44.8K 1.8% 22
2014
Q2 		$3.45M Buy
15,475
+6,035
+64% +$1.25M 1.5% 24
2014
Q1 		$1.94M Buy
9,440
+7,550
+399% +$1.5M 0.87% 47
2013
Q4 		$318K Buy
+1,890
New +$295K 0.13% 70

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Groesbeck Investment Management's AGN Position: Q4 2017 in Review

Groesbeck Investment Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,175 shares — an estimated $241K sold.

Groesbeck Investment Management first reported a position in AGN in Q4 2013 and held it in 16 quarters. The position peaked at $7.85M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Groesbeck Investment Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Groesbeck Investment Management sold 1,175 Allergan plc shares in Q4 2017, an estimated $241K.
  • Groesbeck Investment Management first reported a position in Allergan plc in Q4 2013 and held it in 16 quarters.
  • Groesbeck Investment Management's Allergan plc position peaked at $7.85M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Groesbeck Investment Management's 13F filing for Q4 2017, filed 7 Feb 2018.